{
    "paper_id": "PMC7152001",
    "metadata": {
        "title": "Cardiovascular Disease",
        "authors": [
            {
                "first": "J\u00f6rg",
                "middle": [],
                "last": "Mayer",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Thomas",
                "middle": [
                    "M."
                ],
                "last": "Donnelly",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Cardiovascular disease refers to any disease process primarily involving the heart and/or blood vessels.",
            "cite_spans": [],
            "section": "Definition ::: Basic Information\u00a0",
            "ref_spans": []
        },
        {
            "text": "Cardiovascular disease is being diagnosed more commonly in rabbits. Congestive heart failure, both right- and left-sided, valvular disease, myocardial disease, congenital disease, vascular disease, arteriosclerosis, and atherosclerosis all have been described in the rabbit.",
            "cite_spans": [],
            "section": "Synonyms ::: Basic Information\u00a0",
            "ref_spans": []
        },
        {
            "text": "Incidence of acquired cardiovascular disease increases with age.",
            "cite_spans": [],
            "section": "Species, Age, Sex ::: Epidemiology ::: Basic Information\u00a0",
            "ref_spans": []
        },
        {
            "text": "\n\u2022Giant breeds are more prone to dilated cardiomyopathy.\u2022Arteriosclerosis has a higher incidence in New Zealand white rabbits and a lower incidence in Dutch rabbits.\u2022Some laboratory strains have been bred with a predisposition to develop atherosclerosis as research models (e.g., Watanabe heritable hyperlipidemic rabbit, St. Thomas's Hospital rabbit strain).\n",
            "cite_spans": [],
            "section": "Genetics and Breed Predisposition ::: Epidemiology ::: Basic Information\u00a0",
            "ref_spans": []
        },
        {
            "text": "\n\u2022Genetics\u2022Dietary factors: cholesterol levels >0.5%, peanut oil in the diet, high levels of dietary saturated fat, vitamin E deficiency\u2022Chronic stress (e.g., from overcrowding)\u2022Hypertension\u2022Hypercalcemia secondary to hypervitaminosis D or chronic renal insufficiency\u2022Infection with pathogens that may cause cardiovascular disease (e.g., Pasteurella multocida, Staphylococcus spp., Salmonella spp., Clostridium piriformis, Streptococcus viridans, Coronavirus, and Encephalitozoon cuniculi [see Encephalitozoonosis])\u2022Doxorubicin has been shown experimentally to cause cardiac disease.\u2022Xylazine anesthesia can induce cardiomyopathy.\n",
            "cite_spans": [],
            "section": "Risk Factors ::: Epidemiology ::: Basic Information\u00a0",
            "ref_spans": []
        },
        {
            "text": "\n\u2022Very low risk of spread of infectious cardiac disease; cardiovascular lesions develop only occasionally after acute infection\u2022\nSalmonella spp. and E. cuniculi have some zoonotic risk.\n",
            "cite_spans": [],
            "section": "Contagion and Zoonosis ::: Epidemiology ::: Basic Information\u00a0",
            "ref_spans": []
        },
        {
            "text": "Rabbits recovering from P. multocida, Salmonella spp., and C. piriformis infections occasionally develop cardiomyopathy.",
            "cite_spans": [],
            "section": "Associated Conditions and Disorders ::: Epidemiology ::: Basic Information\u00a0",
            "ref_spans": []
        },
        {
            "text": "Cardiovascular disease can be a life-threatening condition in some rabbits; in others, there may be few or no outward clinical signs.",
            "cite_spans": [],
            "section": "Disease Forms/Subtypes ::: Clinical Presentation ::: Basic Information\u00a0",
            "ref_spans": []
        },
        {
            "text": "\n\u2022Weakness\u2022Lethargy\u2022Weight loss (see Anorexia)\u2022Poor exercise tolerance\u2022Dyspnea\u2022Collapsing episodes\u2022Failure to grow\u2022Distended abdomen\n",
            "cite_spans": [],
            "section": "History, Chief Complaint ::: Clinical Presentation ::: Basic Information\u00a0",
            "ref_spans": []
        },
        {
            "text": "\n\u2022Mucosal color revealing cyanosis (assessment difficult in many breeds)\u2022Cold extremities (ear tips and toes)\u2022Increased capillary refill time\u2022Weak and irregular pulse\u2022Tachypnea\u2022Pulmonary crackles and wheezes\u2022Murmur\u2022Arrhythmia\u2022Exophthalmos\u2022Muffled heart sounds\u2022Ascites\u2022Peripheral edema\n",
            "cite_spans": [],
            "section": "Physical Exam Findings ::: Clinical Presentation ::: Basic Information\u00a0",
            "ref_spans": []
        },
        {
            "text": "Not all findings will be present, and some signs such as ascites are rarely seen in rabbits.",
            "cite_spans": [],
            "section": "Physical Exam Findings ::: Clinical Presentation ::: Basic Information\u00a0",
            "ref_spans": []
        },
        {
            "text": "\n\u2022Coronary arterial circulation is limited; this may predispose rabbits to myocardial ischemia.\u2022Hypercalcemia secondary to hypervitaminosis D or chronic renal insufficiency can lead to mineralization of the aortic arch.\n",
            "cite_spans": [],
            "section": "Etiology and Pathophysiology ::: Basic Information\u00a0",
            "ref_spans": []
        },
        {
            "text": "\n\u2022Respiratory disease (see Lower Respiratory Tract Disorders)\u2022Thoracic abscess\u2022Thymoma (see Thymoma)\u2022Other thoracic neoplasia\n",
            "cite_spans": [],
            "section": "Differential Diagnosis ::: Diagnosis\u00a0",
            "ref_spans": []
        },
        {
            "text": "\n\u2022Radiography: cardiomegaly is the most common finding; pulmonary edema, plural effusion, and ascites are seen less frequently\u2022Echocardiography: most useful for the diagnosis of cardiac masses, pericardial effusions, and valvular disease, and for differentiation between different forms of cardiomyopathy\u2022Electrocardiography (see Electrocardiography, Sec. II): may be normal in the presence of cardiac disease; most useful for diagnosing arrhythmias; normal sinus rhythm seen in rabbits\u2022Blood pressure measurement: hypertension can occur secondary to noncardiac conditions such as chronic renal insufficiency\u2022Hematology: usually normal\u2022Biochemistry: sometimes normal. In cases of secondary hepatocellular swelling, alkaline phosphatase, aspartate transaminase, and alanine transaminase values may be moderately raised. Prerenal azotemia is seen when glomerular filtration rate is reduced.\u2022Pleural fluid cytologic examination and chemistry\u2022Abdominal fluid cytologic examination and chemistry\n",
            "cite_spans": [],
            "section": "Initial Database ::: Diagnosis\u00a0",
            "ref_spans": []
        },
        {
            "text": "\n\u2022Doppler echocardiography\u2022Magnetic resonance imaging\u2022Computed tomography\n",
            "cite_spans": [],
            "section": "Advanced or Confirmatory Testing ::: Diagnosis\u00a0",
            "ref_spans": []
        },
        {
            "text": "\n\u2022Remove underlying cause if possible.\u2022Provide supportive care to minimize clinical signs.\u2022Provide balanced therapeutic therapy to reduce rate of progression of the condition.\u25cbTo extend and improve the patient's quality of life\n\n",
            "cite_spans": [],
            "section": "Therapeutic Goals ::: Treatment\u00a0",
            "ref_spans": []
        },
        {
            "text": "\n\u2022Diuretics (e.g., furosemide 1-10 mg/kg q 8-12 h IM, IV to reduce pulmonary edema and/or reduce ventricular end-diastolic volume)\u2022Angiotensin-converting enzyme (ACE) inhibitors (e.g., benazepril 0.25-0.5 mg/kg q 24 h PO)\u2022Coronary vasodilators (e.g., nitroglycerin 2% ointment \u22481 mm/kg applied topically to the inner ear)\u2022Oxygen therapy (delivered via chamber, tent, face mask, or nasal catheter)\u2022Thoracocentesis to remove any significant effusions\u2022Restricted movement\u2022Monitoring of temperature for hypothermia and hyperthermia\u2022Supportive care and treatment of any secondary gastrointestinal hypomotility\u2022Midazolam 0.1-0.2 mg/kg IM to control stress\n",
            "cite_spans": [],
            "section": "Acute General Treatment ::: Treatment\u00a0",
            "ref_spans": []
        },
        {
            "text": "\n\u2022Benazepril 0.25-0.5 mg/kg q 24 h PO\u2022Furosemide 0.3-4 mg/kg q 8-12 h PO\u2022Pimobendan 0.1-0.3 mg/kg q 12 h PO for its inotropic and vasodilator effects\u2022Digoxin 0.003-0.030 mg/kg q 12-48 h PO (do not use with renal insufficiency)\n",
            "cite_spans": [],
            "section": "Chronic Treatment ::: Treatment\u00a0",
            "ref_spans": []
        },
        {
            "text": "Benazepril, furosemide, and pimobendan combinations may have a clinically deleterious hypotensive effect.",
            "cite_spans": [],
            "section": "Drug Interactions ::: Treatment\u00a0",
            "ref_spans": []
        },
        {
            "text": "Hypotension with combination drug therapy. Occasionally, sole benazepril therapy can have a hypotensive effect.",
            "cite_spans": [],
            "section": "Possible Complications ::: Treatment\u00a0",
            "ref_spans": []
        },
        {
            "text": "\n\u2022Monitor respiration rate and effort, body weight, and blood pressure monthly for the first 4 months. If on benazepril, monitor blood pressure after 3 days or when any deterioration in condition occurs.\u2022Repeat full workup if patient destabilizes.\u2022Perform electrocardiography if arrhythmias are present.\u2022Measure digoxin serum levels after 10 days of therapy. Significant individual variation has been noted. Use 0.5 to 2.0 ng/mL as a guide to therapeutic levels.\n",
            "cite_spans": [],
            "section": "Recommended Monitoring ::: Treatment\u00a0",
            "ref_spans": []
        },
        {
            "text": "Cardiac disease is rarely cured. It is most commonly managed through a balanced therapeutic approach.",
            "cite_spans": [],
            "section": "Prognosis and Outcome\u00a0",
            "ref_spans": []
        },
        {
            "text": "Most often, treatment and management of cardiovascular disease in rabbits are extrapolated and modified from canine and feline medicine.",
            "cite_spans": [],
            "section": "Comments ::: Pearls & Considerations\u00a0",
            "ref_spans": []
        },
        {
            "text": "\n\u2022Minimize stress.\u2022Provide an appropriate diet.\n",
            "cite_spans": [],
            "section": "Prevention ::: Pearls & Considerations\u00a0",
            "ref_spans": []
        }
    ],
    "ref_entries": {},
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Investigation and management of cardiovascular disease in rabbits",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Reusch",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "In Practice",
            "volume": "27",
            "issn": "",
            "pages": "418-425",
            "other_ids": {
                "DOI": []
            }
        }
    }
}